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Tumor necrosis factor alpha -308 promoter
polymorphism and insulin resistance in
overweight and obese adolescents
Polimorfismo do promotor -308 do fator de necrose tumoral alfa e resistência à insulina
em adolescentes com sobrepeso e obesidade
Carlos Alberto Menezes1, Luís Jesuíno de Oliveira Andrade1, Jordian Jorge Pinheiro2, Gustavo Soares Correia2,
Paulo Roberto Santana de Melo3, Fabrício Rios-Santos4
ABSTRACT
Study Model/Methodology: This is a cross-sectional study with a sample of 104 overweight/obese
adolescents, with a mean weight of 52.98 kg ± 22.00, mean age 16.01 ± 2.91 years. We used the
homeostasis model assessment-estimated IR (HOMA-IR) index to quantify the insulin resistance (IR).
The -308 polymorphism of the promoter of TNF-α was performed using polymerase chain reaction-
restriction fragment length polymorphism technique. Statistical analysis of the quantitative measures
was conducted with a student’s t-test. For correlation between the genotype and alleles, we used chi-
square statistical test. To test the heterogeneity between HOMA-IR and the anthropometric parameters
the Mann-Whitney test was used, associated with the Hardy-Weinberg equilibrium. The association
between -308G/A polymorphism of the promoter of TNF-α and HOMA-IR was tested by univariate linear
regression analysis. Objective: Investigate the association between -308G/A polymorphism in the pro-
moter of tumor necrosis factor-alpha (TNF-α) and susceptibility to IR in overweight/obese adolescents.
Results: The prevalence of IR was 18.30% according to the HOMA-IR. The frequency of GG, AG and AA
genotype was found 75 (72.12%), 28 (26.92%) and 1.0 (0.96%) respectively. Allele frequencies for
guanine (G) and adenine (A) were 178 (85.58%) and 30 (14.42%), respectively. The allele A as well as
GA and AA genotype contributed to increase RI (14.42% and 27.88% respectively). Conclusion: The -
308 G/A polymorphism of the promoter of TNF-α can contribute to the IR increase in obese adolescents
with GA and AA genotypes.
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Introduction
Tumor necrosis factor-alpha (TNF-α) is a po-
tent central mediator and pro-inflammatory cytokine
implicated in the immunological response that has
been associated with a large number of human dis-
eases.1,2 The activation of the immune system dur-
ing infection or injury leads to widespread meta-
bolic changes. There is a trend on increasing secre-
tion of cytokines that has been implicated in the
etiology of insulin resistance (IR) and other compo-
nents of the metabolic syndrome, such as glucose
intolerance, obesity, dyslipidemia, and high blood
pressure.3
The increase in the plasma concentration of
TNF-α induces IR states of obesity and type 2 dia-
betes mellitus (DM2).4 Two mechanisms might be
involved in the pathogenesis of inflammation. One
would be oxidative stress and inflammatory changes
resulting from glucose and macronutrient intake,
and the other concerns the increased concentra-
tions of TNF-α itself which would interfere with in-
sulin action by suppressing insulin signal transduc-
tion. This might interfere with the anti-inflamma-
tory effect of insulin, which in turn might promote
inflammation.5 The polymorphism at position -308
in the promoter region of the TNF-α gene may lead
to its increased transcription in adipocytes, and in-
volving a single base change (-308 G/A), in the pro-
moter region, this variant have been linked to IR
and obesity in different ethnic groups.6 It is impor-
tant to note that the TNF-α gene is located in the
chromosomal region 6p21.1-21.3, next to the ma-
jor histocompatibility complex.7
Overweight and obesity in childhood often
precedes the hyperinsulinemic state.8 There is evi-
dence in literature that being overweight during
childhood and adolescence is significantly associ-
ated to metabolic syndrome.9
During puberty there a physiological increase
in insulin levels which has not yet been clearly clari-
fied, and a transient IR develops during puberty,
being accepted as physiological condition.10,11 How-
ever, homeostasis model assessment HOMA-IR dem-
onstrated that obese children with HOMA-IR > 3.16
are regarded carriers of IR non-physiological.12,13
The TNF-α expression is linked with IR, and is
under tight genetic control. Based on this premise
this study aims to investigate the association of the
-308 polymorphism of the promoter region of TNF-α
(-308G/A) with susceptibility to IR in overweight
and obese adolescents.
RESUMO
Modelo de Estudo / Metodologia: Trata-se de um estudo transversal, com uma amostra de 104
adolescentes com sobrepeso/ obesidade, com peso médio de 52,98 kg ± 22,00, média de idade de
16,01 ± 2,91 anos. Utilizamos o índice estimado (HOMA-IR) do modelo de homeostase para quantificar
a resistência insulínica (RI). O polimorfismo do promotor -308 do TNF-α foi realizado utilizando a técnica
de polimorfismo de comprimento de fragmento de restrição. A análise estatística das medidas quantita-
tivas foi realizada com o teste t student. Para a correlação entre o genótipo e os alelos, utilizamos o
teste estatístico qui-quadrado. Para testar a heterogeneidade entre HOMA-IR e os parâmetros antropo-
métricos foi utilizado o teste de Mann-Whitney associado ao equilíbrio de Hardy-Weinberg. A associação
entre o polimorfismo -308G/A do promotor do TNF-α e HOMA-IR foi testada por análise de regressão
linear univariada. Objetivo: investigar a associação entre o polimorfismo -308G/A no promotor do fator
de necrose tumoral alfa (TNF-α) e a susceptibilidade à RI em adolescentes com sobrepeso/ obesidade.
Resultados: A prevalência de RI foi de 18,30% de acordo com o HOMA-IR. A frequência dos genótipos
GG, AG e AA encontrados foram 75 (72,12%), 28 (26,92%) e 1,0 (0,96%), respectivamente. As fre-
quências de alelos para guanina (G) e adenina (A) foram 178 (85,58%) e 30 (14,42%), respectivamen-
te. O alelo A, bem como o genótipo GA e AA, contribuíram para aumentar o RI (respectivamente
14,42% e 27,88%). Conclusão: O polimorfismo -308 G / A do promotor do TNF-α pode contribuir para
o incremento de RI em adolescentes sobrepesos/obesos com genótipos GA e AA.
Palavras chaves: Obesidade. Adolescentes. polimorfismo, Fator de Necrose Tumoral alfa. Resistência
à Insulina.
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Methods
Sample collection
After approval of the study by the ethic
committee of the State University of Santa Cruz,
Ilhéus – Bahia – Brazil, under the presentation
of Certificate for Ethics Assessment (CAAE)
04065412.600005526 of Brazil platform the parents
provided informed written consent for younger than
18 years provided the assent to participate in this
study. Those with an underlying endocrinologic dis-
ease or/and those under medication were excluded
of the study.
The sample consisted of 104 consecutive over-
weight and obese adolescents. After obtaining in-
formed parental consent, 10 ml of peripheral blood
was collected and stored at -20°C.
Anthropometric measurements
Standardized protocols and calibrated equip-
ment were used to obtain measurement of height,
weight, and waist circumference (WC).
The weight measuring procedures: the scale
is set at zero reading scale is set on firm surface,
removes shoes and heavy outer clothing and emp-
ties pockets, steps on center of the platform, with
back toward the scale, both feet on platform. The
height measuring procedures: removes shoes, re-
moves hair ornaments, buns, braids to extent pos-
sible, stands on foot plate portion with back against
stadiometer rule. The WC was measured in cm with
a fiberglass tape with tension gauge, with the sub-
ject standing, feet slightly apart, and abdomen re-
laxed, a horizontal measure was taken at the nar-
rowest point of the torso above the umbilicus and
below the ribcage.
A worldwide standardization of WC is war-
ranted and adult cut-off values were defined. How-
ever, children and adolescents no uniform defini-
tion of WC cut-offs exists in function of physiologi-
cal growth and development. The Brazilian-Iranian-
German (BIG) Study compared children ( 6 to <10
years) and adolescents (10 to <16 years) partici-
pating in the Belo Horizonte Heart Study in Brazil,
and the mean values of WC were for children
59.2±7.2 cm (males) and 58.0±6.8 cm (females),
and adolescents 68.4±10.0 cm (males) and
65.7±8.1 cm (females).14 Body mass index (BMI)
of the patients was calculated using the equation:
BMI= Body weight (Kg)/Height (m2). Subjects whose
BMI values were above 85% in the BMI reference
curve, regarding age and gender, were considered
to be overweight and subjects whose BMI values
were above 95% in the BMI reference curve, were
considered obese. BMI z-score were then calculated
from the 2000 CDC and 2007 WHO data, which clas-
sified them overweight (z-score ≥ 1and < 2) or obese
(BMI z-score ≥ 2). The WC was higher assessed in
the 90th percentile.15
Blood sampling and laboratory assays
DNA extraction: DNA extraction was per-
formed using FlexiGene DNA Kit® (Qiagen, Califor-
nia, USA) and stored at 20°C negative. The
genotyping was performed using polymerase chain
reaction–restriction fragment length polymorphism
(PCR-RFLP) technique according to a previously
published method.16
Biochemical variables: After an overnight fast-
ing, blood was collected between 7 and 10AM in a
1-g/L EDTA collection tube and placed on ice.
Samples were centrifuged for 45 min, transported
on dry ice, and stored at -80°C. Plasma glucose
levels were measured by the glucose oxidase
method and the modified Trinder color reaction cata-
lyzed by the peroxidase enzyme, with reference
value 70-99mg/dl. Insulin levels were measured with
an immunoradiometric assay kit (INS-Irma
Biosource, Nivelles, Belgium). The assay detection
limit was 1 µU/mL, and intra- and interassay coeffi-
cients of variation were 2.2% and 6.5%, respec-
tively, with reference value 28.4 µU/ml. The HOMA-
IR, whereby an increase in value signifies an in-
crease in IR, was calculated using the equation:
HOMA-IR=Fasting insulin (µU/mL) x Fasting glucose
(mg/dL)/405.17,18 HOMA-IR higher than 3.16 was
considered as insulin resistant.12,13
Statistical analysis
Statistical analysis of the quantitative mea-
sures was conducted with the student’s t-test. For
correlation between the genotype and alleles, we
used chi-square statistical test. To test the hetero-
geneity between HOMA-IR and the anthropometric
parameters the Mann-Whitney test as used between
groups of boys e and girls. We used the Hardy-
Weinberg to calculate the allelic equilibrium.
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The association between -308G/A polymor-
phism of the promoter of TNF-α and HOMA-IR was
tested by univariate linear regression analysis. Data
distributions were tested for parametric and non-
parametric by use of student’s t-test.
 Normally distributed data were expressed as
mean. The level of statistical significance accepted
as p <0.05.
Results
A total of 104 adolescents with overweight
and obesity (46 girls, 58 boys) were included in the
study. The mean age was 16.01 ± 2.91 (16-18)
years, mean weight of 52.98± 2.2 kg, and mean
BMI 23.31±6.83 kg/m2 (Table 1).
The frequency of GG, GA and AA genotype
was found to be 75 (0.7212), 28 (0.2692) and 1
(0.0096) respectively. Allele frequencies for gua-
nine (G) and adenine (A) were found to be 178
(0.8558) and 30 (0.1442) respectively.
The distribution of the genotypes and the al-
leles of the TNF-α gene are presented in Table 2.
The TNF-α (-308 GA and GG) genotype distribution
varied between the girls (27.1% and 71.7%) and
boys (26.7% and 72.4%) respectively. The percent-
age of the genotypes GG homozygote was 72.4%
and GA heterozygotes were 27.9%.
TNF-α -308G/A genotype distribution and
anthropometrical parameters in studied individuals
are presented in Table 3. The presence of IR accord-
ing to HOMA-IR ≥ 3.16 was identified in 18.30 % of
obese subjects. This HOMA-IR limit was exceeded
by 7 girls and 10 boys. The aspects of biochemical
variables HOMA-IR and anthropometrical parameters
in studied individuals are shown in Table 4.
Table 1: The clinical characteristics of the group of overweight and obese boys and girls
Boys Girls Total
n= 58 n= 46 n= 104
mean±SD  Range mean±SD  Range mean±SD  Range
Age (years) 15.37±2.98  15.0-18.0 16.07±2.66  16.0-18.0 16.01±2.91  16.0-18.0
Weight (kg) 56.64±2.4  50.0-124.0 48.18±1.7  47.0-95.0 52.98±2.2  47.0-124.0
Height (m) 1.51±0.16  1.45-1.77 1.45±0.13  1.46-1.70 1.48±0.15  1.15-1.77
BMI (Kg/m2) 23.95±2.98  18.8-45.0 22.48±5.82  18.70-37.1 23.31±6.83  18.70-45.0
BMI: Body mass index, Range: minimum – maximum values
Table 2. Polymorphism frequency in boys and girls overweight and obesity
-308 polymorphism of the promoter of TNF-α
Genotypes Allele
GG GA AA A G
n / % n / % n / % P value n % n % P value
n = 104 75 / 72.4 28 / 26.9 1 / 1.0 30/14.4 178 / 85.6 0.084c
Boys 42 / 72.4 16 / 27.6    0 / 0 0.006a 16 / 13.8 100 / 86.2
Girls 33 /71.7 12 / 27.1   1 / 0.96 0.004b 14 / 15.2 78 / 86.2
aPearson ÷2 analysis, ÁÁ vs GG/GA, b Pearson ÷2 analysis ÁÁ/GA vs GG, c controlled for sex, BMI with the use of regression analysis
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Table 3. TNF-α -308G/A genotype distribution and anthropometrical parameters in studied overweight
and obese boys and girls.
TNF-alpha TNF-alpha
-308 G>A -308 G>A
GG GA + AA P value*
Median ± SD Median ± SD
Height (cm) 151.00± 14.43 159.00 ± 13.67 0.851
Weight (Kg) 66.00 ± 20.61 66.50 ± 22.15 0.707
Waist circumference (cm) 90.00 ± 11.18 92.00 ± 14.97 0.940
Body mass index (Kg/m2) 28.25 ± 5.11 28.67 ± 5.68 0.679
SD, Standard Deviation, * Mann–Whitney test.
Table 4. HOMA-IR and anthropometrical parameters in studied individuals.
Abdominal Body mass)
Height (cm) Weight (Kg) circumference (cm) index (Kg/m2
Insulin resistance Median ± SD Median ± SD Median ± SD Median ± SD
Blood glucose
< 99 mg/dL 144 ± 13.73 56.70 ± 18.52 87.00 ± 12.51 26.82 ± 4.73
≥ 99 mg/dL 155.5 ± 14.91 73.00 ± 22.68 93.00 ± 11.64 29.27 ± 5.36
P value* 0.001 0.001 0.001 0.005
HOMA-IR
< 3.16 143 ± 13.55 56.00 ± 18.44 87.00 ± 10.74 26.70 ± 4.37
≥ 3.16 150 ± 14.80 61.25 ± 20.76 89.50 ± 14.98 27.45 ± 5.59
P value* 0.010 0.014 0.021 0.143
Insulin
< 24.9 mU/L 145 ± 14.26 57.50 ± 19.77 88.00 ± 12.67 27.02 ± 4.93
≥ 24.9 mU/L 143.5 ± 13.21 60.50 ± 15.44 89.50 ± 11.94 28.32 ± 4.22
P value* 0.399 0.795 0.749 0.893
SD, Standard  Deviation, * Mann–Whitney test.
The alleles G and A, as well as GG and GA/AA
genotype, contributed to an increase of RI (85.58%
and 14.42% as 72.12% and 27.88% respectively).
Subjects with AA and GA genotypes had significantly
higher levels of HOMA-IR, (p 0.034) than those car-
rying GG genotype. HOMA-IR in subjects with AA
and AG were greater than those with GG genotype
in boys and girls (Table 5).
Discussion
The present study investigated the relation-
ship between TNF-α -308 G/A polymorphisms pro-
moter and the susceptibility to IR in overweight and
obese children and adolescents. The results revealed
a significant association of the TNF-α -308G/A poly-
morphism promoter with IR. The association of this
Medicina (Ribeirão Preto, Online.) 2017;50(6): 358-64 363
Polymorphism  -308 promoter TNFα and insulin resistance
variation in the promoter of the TNF-α gene with
obesity and IR is controversial. Literature shows
negative and positive reports for these associations
over the last years. Different studies have evalu-
ated the TNF-α gene -308G/A polymorphism rela-
tionship to IR and lipid abnormalities in obese chil-
dren suggesting that the -308G/A variation in this
gene does not seem to play an important role in the
setting down of obesity and IR.17,18 However, an
Australian study, in obese non-diabetic subjects,
investigated whether a common polymorphism in
the promoter region ((-308 G/A) of the TNF-α gene
was associated with increased risk for the develop-
ment of IR. The study showed that the polymor-
phism was associated with increased IR in obese
subjects, possibly as a result of increased TNF-α
production.19
A study in vitro showed that the G-308A varia-
tion in the promoter region of TNF-α acts like a much
stronger transcriptional activator than the GG (wild-
type) genotype, and it is suggested that a higher
transcriptional activity would result in higher TNF-α
concentrations followed by decreased insulin sensi-
tivity.20 Experimental studies showed three poten-
tial sites of TNF-α action that can mediate IR in obe-
sity: of the regulation of free fatty acid levels, of
leptin production, and of glucose transporter num-
bers and insulin receptor activity.21,22,23 This result
represents probably the main effect of TNF-α in the
generation of obesity-induced IR due to the impor-
tance of insulin receptor signaling in the generation
of the biological actions of insulin.
Standards for IR in children have not been
established. In an attempt of simplifying the mea-
surement of insulin sensitivity, some methods us-
ing single simultaneously obtained samples of fast-
ing insulin and glucose have been developed. The
derived indexes HOMA-IR, quantitative insulin-sen-
sitivity check index (QUICKI) and fasting glucose-
to-insulin ratio (FGIR) were found to correlate well
with IR. However, HOMA-IR was described as being
a practical alternative for detecting IR in children
due to the highly correlation with fasting insulin in
children and adults.24 HOMA-IR was calculated from
fasting plasma glucose and serum insulin levels, and
the value of 3.16 was chosen as the cut-off point to
define IR.13 A study conducted between 1999-2002
with adolescents enrolled in the National Health and
Nutrition Examination Survey showed a prevalence
of IR in obese children of 52.1% foreshadowing a
worrisome trend on DM2 increase.25 This rate is simi-
lar to results of others studies conducted in devel-
oped countries like France, Italy, and Spain.26,27,28
Interestingly, our findings showed a lower preva-
lence of IR compared to other studies. The higher
levels of IR were associated with a greater degree
of alterations in two criteria of the metabolic syn-
drome evaluated in this study.
Table 5. TNF-α -308G > A genotype distribution and insulin resistance.
TNF-alpha TNF-alpha Odds Ratio (OR)
-308 G/A -308G/A 95% Confidence
Insulin resistance GG GA + AA  interval CI) P value
Blood glucose
< 99 mg/dL 24/36 12/36 OR=0.250 0.249b
≥ 99 mg/dL 8/9 1/9 CI:0.028-2.237
HOMA-IR
< 3.16 20/28 8/28 OR=1.172 0.034ª
≥ 3.16 12/17 5/17 CI:0.276-3.926
Insulin
< 24.9 mU/L 30/41 11/41 OR =2.727 0.567b
≥ 24.9 mU/L 2/4 2/4 CI:0.34-21.790
The genotypic and allelic distributions of all polymorphisms were in Hardy–Weinberg equilibrium.
a ÷2  Yates corrected. b Fisher’s test exact.
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Although the study sample is considered small
for polymorphism research in chronic metabolic dis-
eases, an important fact is the pioneering of this
study in a population of adolescents with obesity in
Northeast Brazil in addition to the heterogeneity of
the sample in a multiracial population.
Our results gathered evidence that -308 G/A
polymorphism of the TNF-α promoter can contrib-
ute to increased IR in adolescents obese with GA e
AA genotypes. However, further studies are neces-
sary to confirm, evaluate and replicate this study in
other populations with obesity.
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